Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EXK - CA29258Y1034 - Common Stock

10.08 USD
+0.29 (+2.96%)
Last: 12/26/2025, 8:04:00 PM
10.1385 USD
+0.06 (+0.58%)
After Hours: 12/26/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, EXK scores 3 out of 10 in our fundamental rating. EXK was compared to 156 industry peers in the Metals & Mining industry. EXK may be in some trouble as it scores bad on both profitability and health. EXK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EXK has reported negative net income.
EXK had a positive operating cash flow in the past year.
Of the past 5 years EXK 4 years were profitable.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

EXK has a worse Return On Assets (-9.27%) than 71.15% of its industry peers.
Looking at the Return On Equity, with a value of -18.53%, EXK is doing worse than 69.23% of the companies in the same industry.
EXK has a Return On Invested Capital of 0.08%. This is comparable to the rest of the industry: EXK outperforms 46.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXK is significantly below the industry average of 13.25%.
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROIC 0.08%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

The Operating Margin of EXK (0.23%) is comparable to the rest of the industry.
EXK's Operating Margin has declined in the last couple of years.
EXK has a Gross Margin (13.03%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 0.23%
PM (TTM) N/A
GM 13.03%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
EXK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EXK has a worse debt to assets ratio.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.02 indicates that EXK is not in any danger for bankruptcy at the moment.
EXK's Altman-Z score of 3.02 is in line compared to the rest of the industry. EXK outperforms 44.87% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that EXK is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.23, EXK perfoms like the industry average, outperforming 45.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACC0.01
WACC9.29%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.79 indicates that EXK may have some problems paying its short term obligations.
EXK has a worse Current ratio (0.79) than 91.03% of its industry peers.
EXK has a Quick Ratio of 0.79. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
EXK's Quick ratio of 0.57 is on the low side compared to the rest of the industry. EXK is outperformed by 87.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.57
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.67%.
The Revenue has grown by 49.22% in the past year. This is a very strong growth!
Measured over the past years, EXK shows a quite strong growth in Revenue. The Revenue has been growing by 12.33% on average per year.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%

3.2 Future

Based on estimates for the next years, EXK will show a very strong growth in Earnings Per Share. The EPS will grow by 53.69% on average per year.
EXK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.07% yearly.
EPS Next Y-13.62%
EPS Next 2Y206.7%
EPS Next 3Y115.11%
EPS Next 5Y53.69%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 17.01, the valuation of EXK can be described as rather expensive.
Based on the Price/Forward Earnings ratio, EXK is valued a bit cheaper than the industry average as 64.10% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of EXK to the average of the S&P500 Index (24.04), we can say EXK is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 17.01
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.63
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as EXK's earnings are expected to grow with 115.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y206.7%
EPS Next 3Y115.11%

0

5. Dividend

5.1 Amount

No dividends for EXK!.
Industry RankSector Rank
Dividend Yield 0%

ENDEAVOUR SILVER CORP

NYSE:EXK (12/26/2025, 8:04:00 PM)

After market: 10.1385 +0.06 (+0.58%)

10.08

+0.29 (+2.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners55.62%
Inst Owner Change18.96%
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap2.97B
Revenue(TTM)337.14M
Net Income(TTM)-94.29M
Analysts80
Price Target10.73 (6.45%)
Short Float %5.67%
Short Ratio1.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-354.6%
Min EPS beat(2)-595.05%
Max EPS beat(2)-114.14%
EPS beat(4)1
Avg EPS beat(4)-1434.73%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1023.35%
EPS beat(12)2
Avg EPS beat(12)-714.54%
EPS beat(16)3
Avg EPS beat(16)-577.87%
Revenue beat(2)2
Avg Revenue beat(2)8.49%
Min Revenue beat(2)0.04%
Max Revenue beat(2)16.94%
Revenue beat(4)3
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)16.94%
Revenue beat(8)7
Avg Revenue beat(8)2.97%
Revenue beat(12)9
Avg Revenue beat(12)1.92%
Revenue beat(16)10
Avg Revenue beat(16)-0.39%
PT rev (1m)0.56%
PT rev (3m)40.49%
EPS NQ rev (1m)-8%
EPS NQ rev (3m)53.33%
EPS NY rev (1m)-325%
EPS NY rev (3m)-376.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.09%
Revenue NY rev (1m)5.52%
Revenue NY rev (3m)10.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.01
P/S 8.8
P/FCF N/A
P/OCF 63.12
P/B 5.83
P/tB 5.83
EV/EBITDA 54.63
EPS(TTM)-0.15
EYN/A
EPS(NY)0.59
Fwd EY5.88%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.16
OCFY1.58%
SpS1.15
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROCE 0.1%
ROIC 0.08%
ROICexc 0.08%
ROICexgc 0.08%
OM 0.23%
PM (TTM) N/A
GM 13.03%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 321.73%
Cap/Sales 52.32%
Interest Coverage 0.06
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.57
Altman-Z 3.02
F-Score3
WACC9.29%
ROIC/WACC0.01
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y-13.62%
EPS Next 2Y206.7%
EPS Next 3Y115.11%
EPS Next 5Y53.69%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%
EBIT growth 1Y-91.44%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year123.81%
EBIT Next 3Y140.25%
EBIT Next 5Y52.95%
FCF growth 1Y-134.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.01%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status for EXK stock?

ChartMill assigns a valuation rating of 2 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Overvalued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for EXK stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to decline by -13.62% in the next year.